Co-Diovan 160 mg/12.5 mg and Voclosporin: interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Combined effects can increase potassium and kidney-related adverse-effect risk.
Clinical significance and safety
Co-Diovan 160 mg/12.5 mg contains a potassium-raising medicine in a class identified by voclosporin labeling. Potassium and kidney function should be monitored according to the treating team’s plan; the combination is not automatically contraindicated for every patient. New weakness, palpitations or a significant reduction in urine output needs assessment.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.